Your browser doesn't support javascript.
loading
Therapeutic efficacy of antibody-drug conjugates targeting GD2-positive tumors.
Kalinovsky, Daniel V; Kibardin, Alexey V; Kholodenko, Irina V; Svirshchevskaya, Elena V; Doronin, Igor I; Konovalova, Mariya V; Grechikhina, Maria V; Rozov, Fedor N; Larin, Sergey S; Deyev, Sergey M; Kholodenko, Roman V.
Afiliación
  • Kalinovsky DV; Department of Immunology, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia.
  • Kibardin AV; Dmitriy Rogachev National Medical Research Center of Pediatric Hematology, Oncology, and Immunology, Moscow, Russia.
  • Kholodenko IV; Orekhovich Institute of Biomedical Chemistry, Moscow, Russia.
  • Svirshchevskaya EV; Department of Immunology, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia.
  • Doronin II; Department of Immunology, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia.
  • Konovalova MV; Real Target LLC, Moscow, Russia.
  • Grechikhina MV; Department of Immunology, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia.
  • Rozov FN; Department of Immunology, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia.
  • Larin SS; Lomonosov Moscow State University, Moscow, Russia.
  • Deyev SM; Dmitriy Rogachev National Medical Research Center of Pediatric Hematology, Oncology, and Immunology, Moscow, Russia.
  • Kholodenko RV; Department of Immunology, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia.
J Immunother Cancer ; 10(6)2022 06.
Article en En | MEDLINE | ID: mdl-35764367

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inmunoconjugados / Melanoma / Neuroblastoma / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: J Immunother Cancer Año: 2022 Tipo del documento: Article País de afiliación: Rusia Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inmunoconjugados / Melanoma / Neuroblastoma / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: J Immunother Cancer Año: 2022 Tipo del documento: Article País de afiliación: Rusia Pais de publicación: Reino Unido